1. Home
  2. NVCR vs LADR Comparison

NVCR vs LADR Comparison

Compare NVCR & LADR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • LADR
  • Stock Information
  • Founded
  • NVCR 2000
  • LADR 2008
  • Country
  • NVCR Switzerland
  • LADR United States
  • Employees
  • NVCR N/A
  • LADR N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • LADR Real Estate Investment Trusts
  • Sector
  • NVCR Health Care
  • LADR Real Estate
  • Exchange
  • NVCR Nasdaq
  • LADR Nasdaq
  • Market Cap
  • NVCR 1.4B
  • LADR 1.5B
  • IPO Year
  • NVCR 2015
  • LADR 2014
  • Fundamental
  • Price
  • NVCR $12.15
  • LADR $11.63
  • Analyst Decision
  • NVCR Buy
  • LADR Buy
  • Analyst Count
  • NVCR 7
  • LADR 2
  • Target Price
  • NVCR $28.79
  • LADR $12.75
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • LADR 504.1K
  • Earning Date
  • NVCR 10-29-2025
  • LADR 10-23-2025
  • Dividend Yield
  • NVCR N/A
  • LADR 7.89%
  • EPS Growth
  • NVCR N/A
  • LADR N/A
  • EPS
  • NVCR N/A
  • LADR 0.70
  • Revenue
  • NVCR $630,160,000.00
  • LADR $243,794,000.00
  • Revenue This Year
  • NVCR $6.68
  • LADR N/A
  • Revenue Next Year
  • NVCR $7.01
  • LADR $17.71
  • P/E Ratio
  • NVCR N/A
  • LADR $16.67
  • Revenue Growth
  • NVCR 14.58
  • LADR N/A
  • 52 Week Low
  • NVCR $10.87
  • LADR $9.68
  • 52 Week High
  • NVCR $34.13
  • LADR $12.25
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 46.57
  • LADR 57.90
  • Support Level
  • NVCR $11.98
  • LADR $11.50
  • Resistance Level
  • NVCR $12.83
  • LADR $11.88
  • Average True Range (ATR)
  • NVCR 0.56
  • LADR 0.14
  • MACD
  • NVCR 0.15
  • LADR -0.00
  • Stochastic Oscillator
  • NVCR 25.49
  • LADR 43.27

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About LADR Ladder Capital Corp

Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments include loans: which derives maximum profit; securities; and real estate.

Share on Social Networks: